The societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impact
Abstract Background Diabetes mellitus, cardiovascular diseases, chronic kidney disease, and thyroid diseases are chronic diseases that require regular monitoring through blood tests. This paper first investigates the experiences of chronic care patients with venipuncture and their expectations of an...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-12-01
|
| Series: | BMC Health Services Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12913-022-08782-w |
| _version_ | 1811292625078059008 |
|---|---|
| author | Deon Lingervelder Michelle M. A. Kip Eva D. Wiese Hendrik Koffijberg Maarten J. Ijzerman Ron Kusters |
| author_facet | Deon Lingervelder Michelle M. A. Kip Eva D. Wiese Hendrik Koffijberg Maarten J. Ijzerman Ron Kusters |
| author_sort | Deon Lingervelder |
| collection | DOAJ |
| description | Abstract Background Diabetes mellitus, cardiovascular diseases, chronic kidney disease, and thyroid diseases are chronic diseases that require regular monitoring through blood tests. This paper first investigates the experiences of chronic care patients with venipuncture and their expectations of an at-home blood-sampling device, and then assesses the impact on societal costs of implementing such a device in current practice. Methods An online survey was distributed among chronic care patients to gain insight into their experience of blood sampling in current practice, and their expectations of an at-home blood-sampling device. The survey results were used as input parameters in a patient-level monte carlo analysis developed to represent a hypothetical cohort of Dutch chronically ill patients to investigate the impact on societal costs compared to usual care. Results In total, 1311 patients participated in the survey, of which 31% experience the time spent on the phlebotomy appointment as a burden. Of all respondents, 71% prefer to use an at-home blood-sampling device to monitor their chronic disease. The cost analysis indicated that implementing an at-home blood-sampling device increases the cost of phlebotomy itself by €27.25 per patient per year, but it reduces the overall societal costs by €24.86 per patient per year, mainly due to limiting productivity loss. Conclusions Patients consider an at-home blood-sampling device to be more user-friendly than venous phlebotomy on location. Long waiting times and crowded locations can be avoided by using an at-home blood-sampling device. Implementing such a device is likely cost-saving as it is expected to reduce societal costs. |
| first_indexed | 2024-04-13T04:49:07Z |
| format | Article |
| id | doaj.art-c20fa77e2f494ce682bcd32ed12e8776 |
| institution | Directory Open Access Journal |
| issn | 1472-6963 |
| language | English |
| last_indexed | 2024-04-13T04:49:07Z |
| publishDate | 2022-12-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Health Services Research |
| spelling | doaj.art-c20fa77e2f494ce682bcd32ed12e87762022-12-22T03:01:46ZengBMCBMC Health Services Research1472-69632022-12-0122111110.1186/s12913-022-08782-wThe societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impactDeon Lingervelder0Michelle M. A. Kip1Eva D. Wiese2Hendrik Koffijberg3Maarten J. Ijzerman4Ron Kusters5Health Technology and Services Research Department, Technical Medical Centre, University of TwenteHealth Technology and Services Research Department, Technical Medical Centre, University of TwenteHealth Technology and Services Research Department, Technical Medical Centre, University of TwenteHealth Technology and Services Research Department, Technical Medical Centre, University of TwenteHealth Technology and Services Research Department, Technical Medical Centre, University of TwenteHealth Technology and Services Research Department, Technical Medical Centre, University of TwenteAbstract Background Diabetes mellitus, cardiovascular diseases, chronic kidney disease, and thyroid diseases are chronic diseases that require regular monitoring through blood tests. This paper first investigates the experiences of chronic care patients with venipuncture and their expectations of an at-home blood-sampling device, and then assesses the impact on societal costs of implementing such a device in current practice. Methods An online survey was distributed among chronic care patients to gain insight into their experience of blood sampling in current practice, and their expectations of an at-home blood-sampling device. The survey results were used as input parameters in a patient-level monte carlo analysis developed to represent a hypothetical cohort of Dutch chronically ill patients to investigate the impact on societal costs compared to usual care. Results In total, 1311 patients participated in the survey, of which 31% experience the time spent on the phlebotomy appointment as a burden. Of all respondents, 71% prefer to use an at-home blood-sampling device to monitor their chronic disease. The cost analysis indicated that implementing an at-home blood-sampling device increases the cost of phlebotomy itself by €27.25 per patient per year, but it reduces the overall societal costs by €24.86 per patient per year, mainly due to limiting productivity loss. Conclusions Patients consider an at-home blood-sampling device to be more user-friendly than venous phlebotomy on location. Long waiting times and crowded locations can be avoided by using an at-home blood-sampling device. Implementing such a device is likely cost-saving as it is expected to reduce societal costs.https://doi.org/10.1186/s12913-022-08782-wChronic diseasesPhlebotomyAt-home blood-samplingCost-minimization analysis |
| spellingShingle | Deon Lingervelder Michelle M. A. Kip Eva D. Wiese Hendrik Koffijberg Maarten J. Ijzerman Ron Kusters The societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impact BMC Health Services Research Chronic diseases Phlebotomy At-home blood-sampling Cost-minimization analysis |
| title | The societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impact |
| title_full | The societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impact |
| title_fullStr | The societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impact |
| title_full_unstemmed | The societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impact |
| title_short | The societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impact |
| title_sort | societal impact of implementing an at home blood sampling device for chronic care patients patient preferences and cost impact |
| topic | Chronic diseases Phlebotomy At-home blood-sampling Cost-minimization analysis |
| url | https://doi.org/10.1186/s12913-022-08782-w |
| work_keys_str_mv | AT deonlingervelder thesocietalimpactofimplementinganathomebloodsamplingdeviceforchroniccarepatientspatientpreferencesandcostimpact AT michellemakip thesocietalimpactofimplementinganathomebloodsamplingdeviceforchroniccarepatientspatientpreferencesandcostimpact AT evadwiese thesocietalimpactofimplementinganathomebloodsamplingdeviceforchroniccarepatientspatientpreferencesandcostimpact AT hendrikkoffijberg thesocietalimpactofimplementinganathomebloodsamplingdeviceforchroniccarepatientspatientpreferencesandcostimpact AT maartenjijzerman thesocietalimpactofimplementinganathomebloodsamplingdeviceforchroniccarepatientspatientpreferencesandcostimpact AT ronkusters thesocietalimpactofimplementinganathomebloodsamplingdeviceforchroniccarepatientspatientpreferencesandcostimpact AT deonlingervelder societalimpactofimplementinganathomebloodsamplingdeviceforchroniccarepatientspatientpreferencesandcostimpact AT michellemakip societalimpactofimplementinganathomebloodsamplingdeviceforchroniccarepatientspatientpreferencesandcostimpact AT evadwiese societalimpactofimplementinganathomebloodsamplingdeviceforchroniccarepatientspatientpreferencesandcostimpact AT hendrikkoffijberg societalimpactofimplementinganathomebloodsamplingdeviceforchroniccarepatientspatientpreferencesandcostimpact AT maartenjijzerman societalimpactofimplementinganathomebloodsamplingdeviceforchroniccarepatientspatientpreferencesandcostimpact AT ronkusters societalimpactofimplementinganathomebloodsamplingdeviceforchroniccarepatientspatientpreferencesandcostimpact |